UNSPSC 51281653: Kanamycin a

This classification denotes an aminoglycoside antibiotic with the molecular formula C18H36N4O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EQK9Q303C5, chemically known as d-streptamine, o-3-amino-3-deoxy-.alpha.-d-glucopyranosyl-(1->6)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4))-2-deoxy-, but more generally known as kanamycin a, which bears US NIH Compound Identifier 6032.

European Medicines Agency schedules kanamycin a or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08362MIG. Most nations, for tariff purposes, schedule kanamycin a under HS 29419000. Kanamycin a bears US NLM identifiers UMLS ID C0022489 and NCI Concept Code C76151. SMILES: C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N.

UNSPSC 51281653 Kanamycin a is a Commodity code, but the recent state and local opportunities tagged under it show minimal direct relevance to kanamycin (an aminoglycoside antibiotic) and instead reflect broader pharmaceutical and medical supply procurement activity. The code appears in solicitations for naloxone and drug deactivation systems, generic multi-source pharmaceuticals through cooperative purchasing, direct-to-manufacturer prescription programs, and emergency medical and first aid supplies for fire departments. State and local governments buying under this nominal code are acquiring finished pharmaceutical products, OTC medications, medical consumables, and specialty supplies—not bulk drug substances. Issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas HHS Commission), cities (Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple state and local entities across regions including Oregon).

Recent opportunities span Florida, Texas, Minnesota, and Oregon. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP on January 20, 2026 for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with proposals due March 26, 2026; Seminole County, Florida posted an IFB on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (note: this date appears to predate the posting); the City of Tampa issued an ITB on March 25, 2026 for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, due March 13, 2026, with an estimated contract value of $700,000.00 and an SLBE set-aside; and the Texas HHS Commission posted an RFI on April 3, 2026 regarding direct-to-manufacturer prescription capabilities. The code shows mixed and scattered activity with no clear concentration in any single state or jurisdiction type.